A UK company called Hvivo runs a quarantine unit in a laboratory where up to 24 volunteers will be paid to be infected with two strains of the coronavirus (0C43 and 229E), both of which can cause severe respiratory symptoms. Then they will be observed over a two week period.
During those 14 days, the quarantined volunteers will be monitored by doctors and nurses in protective gear, who will be their only human contact. Swabs and dirty tissues will also be collected in order to measure the viral load. It is thought that the infected volunteers will likely experience mild symptoms of a cough or cold.
“Drugs companies can get a very good idea within a few months of starting a vaccine study whether it’s working or not, using such a small sample of people,” said Andrew Catchpole, Hvivo’s chief scientist.
Sooooo… Does this sound like something you want to pursue?
PROs: Two weeks of rest and relaxation, free from annoying family members and coworkers.
(via The Times; photo: Pixabay)